.Pharmacolibrary.Drugs.ATC.D.D07XA01

Information

name:Hydrocortisone
ATC code:D07XA01
route:intravenous
n-compartments2

Hydrocortisone is a corticosteroid hormone (glucocorticoid) used to treat conditions caused by low corticosteroid levels, such as adrenocortical insufficiency (Addison's disease). It is also used for its anti-inflammatory and immunosuppressive effects in allergic reactions, autoimmune disorders, and other conditions. Hydrocortisone is approved and widely used today in various formulations (oral, intravenous, topical, and others).

Pharmacokinetics

Pharmacokinetic parameters in healthy adult volunteers after intravenous administration.

References

  1. Hamitouche, N, et al., & Laviolle, B (2017). Population Pharmacokinetic-Pharmacodynamic Model of Oral Fludrocortisone and Intravenous Hydrocortisone in Healthy Volunteers. The AAPS journal 19(3) 727–735. DOI:10.1208/s12248-016-0041-9 PUBMED:https://pubmed.ncbi.nlm.nih.gov/28083797

  2. Vincze, I, et al., & Kopitkó, C (2022). Assessment of Antibiotic Pharmacokinetics, Molecular Biomarkers and Clinical Status in Critically Ill Adults Diagnosed with Community-Acquired Pneumonia and Receiving Intravenous Piperacillin/Tazobactam and Hydrocortisone over the First Five Days of Intensive Care: An Observational Study (STROBE Compliant). Journal of clinical medicine 11(14) –. DOI:10.3390/jcm11144140 PUBMED:https://pubmed.ncbi.nlm.nih.gov/35887904

  3. Knych, HK, et al., & Kass, PH (2019). Pharmacokinetics of intravenous flumetasone and effects on plasma hydrocortisone concentrations and inflammatory mediators in the horse. Equine veterinary journal 51(2) 238–245. DOI:10.1111/evj.13002 PUBMED:https://pubmed.ncbi.nlm.nih.gov/30080272

Revisions


Generated at 2025-07-21T18:21:10Z by OpenModelicaOpenModelica 1.25.1 using GenerateDoc.mos